Home › Research › Long-term cohort studies
Prediabetes as a critical stage for risk of dementia and stroke: evidence from the UK Biobank and Mendelian randomization.:evidence from the UK Biobank and Mendelian Randomization
Fariba Ahmadizar. Pure Amsterdam UMC, 2026-01-01
Topic: Risk, prevention and care in population studies
Plain-language summary
During a median 13.7 years of follow-up, prediabetes (n=52,693) was associated with higher risks of vascular dementia (hazard ratio (HR):1.36; 95% confidence interval (CI): 1.14-1.61), stroke (HR:1.09; 95% CI: 1.01-1.16), ischemic stroke (HR:1.10; 95% CI: 1.02-1.19), and intracerebral hemorrhage (HR:1.19; 95% CI: 1.01-1.39) compared with normoglycemia, after adjustment for major confounding factors and across extensive sensitivity analyses. In the brain MRI cohort (N=39,996), gray matter volumes (β = -0.04, 95% CI -0.07 to -0.01) and hippocampal volumes (β = -0.03, 95% CI -0.06 to 0.00) were smaller, and log-transformed white matter hyperintensity volume (β = 0.04, 95% CI 0.01 to 0.07) was larger in prediabetes. Spline models indicated that adverse outcomes were associated with higher HbA1c levels, even before the diagnostic threshold for T2D was reached. Risks were further elevated in T2D. MR analyses supported causal effects of glycemia on dementia, stroke and hippocampal atrophy. Prediabetes is not a benign state: even modest HbA1c elevations are linked to vascular dementia, stroke, and brain structural decline. These risks emerge below current diagnostic glycemic thresholds, underscoring prediabetes as a critical stage for early intervention to preserve brain health.
What this study adds
Evidence grade: Moderate
The record lists 52,693 participants. This study found that prediabetes was associated with higher risks of vascular dementia, stroke, and brain structural decline, with risks emerging below current diagnostic thresholds for type 2 diabetes. Reported effect size: HR:1.09; HR:1.10; HR:1.19.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Ahmadizar, F. (2026). Prediabetes as a critical stage for risk of dementia and stroke: evidence from the UK Biobank and Mendelian randomization.:evidence from the UK Biobank and Mendelian Randomization. Pure Amsterdam UMC. https://doi.org/10.1093/eurjpc/zwag278
Vancouver
Ahmadizar F. Prediabetes as a critical stage for risk of dementia and stroke: evidence from the UK Biobank and Mendelian randomization.:evidence from the UK Biobank and Mendelian Randomization. Pure Amsterdam UMC. 2026. doi:10.1093/eurjpc/zwag278.
BibTeX
@article{ahmadizar2026-f529a151,
author = {Ahmadizar, Fariba},
title = {{Prediabetes as a critical stage for risk of dementia and stroke: evidence from the UK Biobank and Mendelian randomization.:evidence from the UK Biobank and Mendelian Randomization}},
journal = {Pure Amsterdam UMC},
year = {2026},
doi = {10.1093/eurjpc/zwag278},
url = {https://doi.org/10.1093/eurjpc/zwag278}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- During a median 13.7 years of follow-up, prediabetes (n=52,693) was associated with higher risks of vascular dementia (hazard ratio (HR):1.36; 95% confidence interval (CI): 1.14-1.61), stroke (HR:1.09; 95% CI: 1.01-1.16), ischemic stroke (HR:1.10; 95% CI: 1.02-1.19), and intracerebral hemorrhage (HR:1.19; 95% CI: 1.01-1.39) compared with normoglycemia, after adjustment for major confounding factors and across extensive sensitivity analyses.
- In the brain MRI cohort (N=39,996), gray matter volumes (β = -0.04, 95% CI -0.07 to -0.01) and hippocampal volumes (β = -0.03, 95% CI -0.06 to 0.00) were smaller, and log-transformed white matter hyperintensity volume (β = 0.04, 95% CI 0.01 to 0.07) was larger in prediabetes.
- Spline models indicated that adverse outcomes were associated with higher HbA1c levels, even before the diagnostic threshold for T2D was reached.
- MR analyses supported causal effects of glycemia on dementia, stroke and hippocampal atrophy.
- Prediabetes is not a benign state: even modest HbA1c elevations are linked to vascular dementia, stroke, and brain structural decline.
Why it matters
This study found that prediabetes was associated with higher risks of vascular dementia, stroke, and brain structural decline, with risks emerging below current diagnostic thresholds for type 2 diabetes. It suggests that prediabetes is a critical stage for early intervention to preserve brain health, but it does not show that treating prediabetes prevents dementia.
Study details
- Participants52,693
- Effect sizeHR:1.09; HR:1.10; HR:1.19
- Evidence strengthModerate
How this study scored 48/100
Published in a peer-reviewed journal. Scored zero for study design and randomized / blinded because the record does not state it. We have no data on journal's citation record, so that was left out: it earned 46 of the 96 points we could judge it on, which is 48 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Pure Amsterdam UMC) |
| Journal's citation record | — / 4 | No journal record from OpenAlex — left out of this score |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 5 / 5 | 2026 — within 1 year(s) of the newest study here |
| Sample size | 4 / 4 | 52,693 participants |
| Effect reported | 3 / 3 | Effect reported with a statistic (interval, p-value, ratio or similar) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 1 / 7 | Cited 1 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.5 citations a year over 2 year(s) since 2026 |
| Impact for its field and year | 0 / 6 | Cited 0.0× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Fariba Ahmadizar: h-index 26 (OpenAlex, whole career) |
| Institution's track record | 3 / 3 | Harvard University: institution h-index 3,235 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 8 institution(s) in 3 countries |
| Indexed in PubMed | 1 / 2 | Not in PubMed, but has a DOI |
| Free to read | 2 / 2 | Free to read |
| Points | 46 / 96 | Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 46 of the 96 points we could judge it on is 48 out of 100. |
| Total | 48 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1093/eurjpc/zwag278
- Original source →
- Free full text: European Journal of Preventive Cardiology →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Long-term cohort studies from nearby years
Also tagged “biobank”
1,084 studies in the library carry the topic tag “biobank”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,084 tagged studies.